Back to top

Enliven price target raised to $65 from $56 at H.C. Wainwright

H.C. Wainwright analyst Robert Burns raised the firm’s price target on Enliven (ELVN) to $65 from $56 and keeps a Buy rating on the shares after ra...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Enliven Therapeutics, Inc. (ELVN)